SPEGRA Dolutegravir + Emtricitabine + Tenofovir Alafenamide

Modern HIV treatment focuses on high efficacy, better safety, and long-term tolerability. Unnati Pharmax, a reliable pharmaceutical exporter from India, supplies SPEGRA Tablets, an advanced single-tablet antiretroviral regimen containing Dolutegravir, Emtricitabine, and Tenofovir Alafenamide (TAF). SPEGRA is widely used for HIV-1 treatment and is recommended in many international treatment guidelines due to its strong viral suppression and improved safety profile. What is SPEGRA Tablet? SPEGRA Tablet is a fixed-dose combination antiretroviral medicine containing: Dolutegravir – 50 mg Emtricitabine – 200 mg Tenofovir Alafenamide – 25 mg This formulation includes: INSTI: Dolutegravir NRTIs: Emtricitabine & Tenofovir Alafenamide Together, these medicines provide potent and durable HIV viral suppression. Uses of SPEGRA Tablet SPEGRA Tablets are prescribed for: Treatment of HIV-1 infection First-line antiretroviral therapy (ART) Switch therapy for stable HIV patients Long-term viral load suppression Improvement of immune system health Because SPEGRA is taken once daily, it helps improve patient adherence and treatment success. How Does SPEGRA Work? SPEGRA works by attacking HIV at multiple stages: Dolutegravir blocks the integrase enzyme, preventing viral DNA integration Emtricitabine and Tenofovir Alafenamide inhibit reverse transcriptase HIV replication is stopped Viral load is significantly reduced As a result, HIV progression is controlled and immune function is preserved. Dosage and Administration Taken once daily, with or without food Should be taken at the same time each day Regular monitoring as advised by a healthcare professional ⚠️ Always follow the dosage prescribed by a doctor. Possible Side Effects SPEGRA is generally well tolerated. Some patients may experience: Headache Nausea Fatigue Diarrhea Insomnia Serious side effects are uncommon but should be reported immediately. Why Choose Unnati Pharmax for SPEGRA Tablets? Unnati Pharmax is a trusted exporter of HIV and antiviral medicines from India, serving global healthcare markets. Our Key Advantages WHO-GMP & ISO-certified manufacturing partners Competitive export pricing Complete regulatory & export documentation Reliable global logistics support Custom packaging as per importing country requirements We export SPEGRA Tablets to Africa, Asia, Latin America, and other international regions. Product Details Product Name: SPEGRA Tablet Composition: Dolutegravir + Emtricitabine + Tenofovir Alafenamide Dosage Form: Tablet Therapeutic Category: Antiretroviral (HIV Medicine) Packaging: Export-oriented packing available FAQs – SPEGRA Tablet Is SPEGRA used as first-line HIV treatment? Yes. SPEGRA is commonly used as a first-line ART regimen due to its high efficacy and safety profile. Is SPEGRA better than older Tenofovir-based medicines? Yes. Tenofovir Alafenamide (TAF) has better kidney and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Is SPEGRA a cure for HIV? No. SPEGRA does not cure HIV but helps control the virus and prevent disease progression. Can Unnati Pharmax export SPEGRA Tablets? Yes. Unnati Pharmax exports SPEGRA Tablets from India with full regulatory compliance. Is a prescription required? Yes. SPEGRA is a prescription-only medication. Conclusion SPEGRA Tablet (Dolutegravir + Emtricitabine + Tenofovir Alafenamide) represents a modern and effective solution for HIV-1 treatment. With a strong focus on quality, affordability, and global supply, Unnati Pharmax ensures reliable access to this advanced antiretroviral medicine worldwide.